{"product_id":"type-2-diabetes-ckd-clinical-guide-2026","title":"Type 2 Diabetes + CKD Clinical Guide 2026","description":"\u003cp class=\"isSelectedEnd\"\u003eManaging type 2 diabetes in a patient with chronic kidney disease requires more than simply lowering A1C.\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003eThis practical 41-page clinical guide helps you connect glycemic control, kidney protection, cardiovascular risk reduction, renal dosing, monitoring, and patient-specific treatment decisions into one clear approach.\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003eBuilt for pharmacy learners and healthcare professionals who want to move from memorizing guidelines to actually applying them in patient care.\u003c\/p\u003e\n\u003ch3\u003eWhat's Inside\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eQuick-start T2DM + CKD patient workup\u003c\/li\u003e\n\u003cli\u003eCKD staging using eGFR and UACR\u003c\/li\u003e\n\u003cli\u003eIndividualized A1C and blood pressure goals\u003c\/li\u003e\n\u003cli\u003eMetformin use and renal considerations\u003c\/li\u003e\n\u003cli\u003eSGLT2 inhibitor selection, dosing, safety, and counseling\u003c\/li\u003e\n\u003cli\u003eGLP-1 therapy and kidney\/CV outcomes\u003c\/li\u003e\n\u003cli\u003eACE inhibitor and ARB management\u003c\/li\u003e\n\u003cli\u003eFinerenone dosing, potassium monitoring, and patient selection\u003c\/li\u003e\n\u003cli\u003eOther glucose-lowering medications in CKD\u003c\/li\u003e\n\u003cli\u003ePractical medication-selection algorithm\u003c\/li\u003e\n\u003cli\u003eRenal dosing and monitoring tables\u003c\/li\u003e\n\u003cli\u003e5 clinical patient cases with reasoning\u003c\/li\u003e\n\u003cli\u003ePatient counseling points\u003c\/li\u003e\n\u003cli\u003ePharmacist workup checklist\u003c\/li\u003e\n\u003cli\u003eClinical pearls and common medication mistakes\u003c\/li\u003e\n\u003cli\u003eGuideline and primary-literature references\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eBuilt for Clinical Application\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003eInstead of focusing only on individual medications, this guide helps answer questions such as:\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003eWhat therapy should I prioritize?\u003cbr\u003eDoes this medication need renal adjustment?\u003cbr\u003eWhat should I monitor after starting therapy?\u003cbr\u003eIs kidney-protective therapy missing even if the A1C is controlled?\u003cbr\u003eWhen should therapy be intensified or deintensified?\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003eThe guide includes a practical treatment pathway, medication thresholds, monitoring strategies, and case-based examples designed to help you work through the whole patient, not just a laboratory value.\u003c\/p\u003e\n\u003ch3\u003eEvidence-Based for 2026\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003eThe guide incorporates the 2026 ADA Standards of Care, KDIGO guidance, U.S. prescribing information, and major kidney and cardiovascular outcome trials, including evidence involving SGLT2 inhibitors, GLP-1 therapy, and finerenone.\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003eVersion 1.1 | 2026 Edition\u003cbr\u003e41-page digital PDF\u003cbr\u003eEvidence reviewed through August 25, 2026\u003c\/p\u003e\n\u003cp\u003eFor educational use only. This resource does not replace patient-specific clinical judgment, current prescribing information, institutional policy, or applicable clinical guidelines.\u003c\/p\u003e","brand":"PharmApplied","offers":[{"title":"Default Title","offer_id":48234810179820,"sku":null,"price":14.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0842\/9132\/2092\/files\/ChatGPTImageAug26_2026at10_12_42PM_1.png?v=1787807634","url":"https:\/\/pharmapplied.com\/products\/type-2-diabetes-ckd-clinical-guide-2026","provider":"PharmApplied","version":"1.0","type":"link"}